CDNA - CareDx, Inc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
102,129
76,569
48,324
40,631
28,144
Cost of Revenue
40,641
32,987
21,371
21,122
10,273
Gross Profit
61,488
43,582
26,953
19,509
17,871
Operating Expenses
Research Development
20,894
14,514
12,388
12,385
9,333
Selling General and Administrative
57,968
43,629
31,721
31,891
20,596
Total Operating Expenses
78,862
58,143
44,109
44,276
29,929
Operating Income or Loss
-17,374
-14,561
-17,156
-24,767
-12,058
Interest Expense
-
3,701
5,863
1,860
1,587
Total Other Income/Expenses Net
-23,244
-29,953
-34,250
-14,735
-62
Income Before Tax
-40,558
-48,215
-57,269
-41,362
-13,707
Income Tax Expense
-1,455
-1,434
-1,709
-1,606
0
Income from Continuing Operations
-39,103
-46,781
-55,560
-39,756
-13,707
Net Income
-39,103
-46,756
-55,469
-39,469
-13,707
Net Income available to common shareholders
-39,103
-46,756
-55,469
-39,469
-13,707
Reported EPS
Basic
-
-1.31
-2.38
-2.39
-1.16
Diluted
-
-1.31
-2.38
-2.39
-1.16
Weighted average shares outstanding
Basic
-
35,639
23,333
16,497
11,861
Diluted
-
35,639
23,333
16,497
11,861
EBITDA
-
-44,514
-51,406
-39,502
-12,058